4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-006880
Chief Business Officer sold 6,944 shares at $69.91 ($485,424)
- Chief Business Officer acquired 6,944 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…